Trial Profile
Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tipranavir (Primary) ; Aspirin; Darunavir/ritonavir; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 03 Oct 2014 New trial record